OA01.05 Three-year Outcomes per PD-L1 Status and Continued Cemiplimab Beyond Progression + Chemotherapy: EMPOWER-Lung 1
| Autor: | Garassino, M.C., Kilickap, S., Özgüroğlu, M., Sezer, A., Gumus, M., Bondarenko, I., Gogishvili, M., Nechaeva, M., Schenker, M., Cicin, I., Fuang, H.G., Kulyaba, Y., Dvorkin, M., Zyuhal, K., Scheusan, R.-I., He, X., Kaul, M., Okoye, E., Li, Y., Li, S., Pouliot, J.-F., Seebach, F., Lowy, I., Gullo, G., Rietschel, P. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology March 2023 18(3) Supplement:e2-e3 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|